Methylphenidate remediates aberrant brain network dynamics in children with attention-deficit/hyperactivity disorder: A randomized controlled trial

Methylphenidate is a widely used first-line treatment for attention deficit/hyperactivity disorder (ADHD), but the underlying circuit mechanisms are poorly understood. Here we investigate whether a single dose of osmotic release oral system methylphenidate can remediate attention deficits and aberra...

Descripción completa

Detalles Bibliográficos
Autores principales: Mizuno, Yoshifumi, Cai, Weidong, Supekar, Kaustubh, Makita, Kai, Takiguchi, Shinichiro, Tomoda, Akemi, Menon, Vinod
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9286726/
https://www.ncbi.nlm.nih.gov/pubmed/35640787
http://dx.doi.org/10.1016/j.neuroimage.2022.119332

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9286726/
https://www.ncbi.nlm.nih.gov/pubmed/35640787
http://dx.doi.org/10.1016/j.neuroimage.2022.119332

Ejemplares similares